Boston Scientific to market Bladder Health Network's female urodynamic testing solutions in the U.S.

Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a co-marketing agreement with Bladder Health Network, a privately held company offering advanced testing solutions for urinary incontinence. Bladder Health Network offers an integrated diagnostic service that combines staffing, equipment, supplies and results analysis, helping to ensure that physicians and their patients have access to testing, interpretation and treatment options for urinary incontinence and other problems related to the urinary system.

As part of the agreement, Boston Scientific's Urology/Gynecology business unit will market Bladder Health Network's female urodynamic testing solutions to U.S. health care providers. Urodynamics employs sophisticated equipment to measure the amount of pressure experienced by the bladder and urethra in order to evaluate the function and efficiency of a patient's urinary system.

"The agreement with Bladder Health Network allows Boston Scientific to introduce health care providers to a platform specifically designed to unite treatment centers with physicians who have advanced expertise in female continence care," said John Pedersen, President of Boston Scientific's Urology/Gynecology business. "This agreement demonstrates Boston Scientific's continuing commitment to the women's health community."

"With Boston Scientific we've found an industry leader who shares our vision of improving the quality of continence care," said John Spivey, President and Chief Executive Officer of Bladder Health Network. "This agreement enhances our ability to deliver compelling solutions to the market, enhance patient care and create better efficiencies for physicians."

It is estimated that urinary incontinence affects one out of four women in the United States and can have a significant impact on quality of life. Symptoms include leaking urine, difficulty emptying the bladder, frequent urination, recurrent infections and loss of bladder support.